$12.39
0.10.81%
Pre-Market: Jul 19, 5:07 PM EDT
15 minutes delayed
Comments
Loading...
Sage Therapeutics
SAGENASDAQ
Sage Therapeutics (SAGE) Forecast
NewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestSage Therapeutics (NASDAQ:SAGE) Stock Quotes, Forecast and News Summary
Sage Therapeutics Stock (NASDAQ: SAGE) stock price, news, charts, stock research, profile.
| Open | - |
| Close | - |
| Volume / Avg. | 0 / 1.22M |
| Day Range | - - - |
| 52 Wk Range | 9.76 - 46.43 |
| Market Cap | $745.66M |
| P/E Ratio | - |
| Dividend Yield | - |
| Exchange | NASDAQ |
| RSI | 62 |
| Short Interest | 10.69% |
| Days to Cover | 3.46 |
Recent News
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
About Sage Therapeutics Inc
Sector
Health Care
Industry
Biotechnology
Sage Therapeutics Inc is a clinical-stage biopharmaceutical company focused on brain health medicine...
Show More
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Sage Therapeutics (SAGE) stock?
You can purchase shares of Sage Therapeutics (NASDAQ:SAGE) through any online brokerage.
Who are Sage Therapeutics (SAGE) competitors?
Other companies in Sage Therapeutics’s space includes: Immunome (NASDAQ:IMNM), Humacyte (NASDAQ:HUMA), 89bio (NASDAQ:ETNB), 4D Molecular Therapeutics (NASDAQ:FDMT) and AnaptysBio (NASDAQ:ANAB).
What is the target price for Sage Therapeutics (SAGE) stock?
There is no analysis for Sage Therapeutics.
What is the forecast for Sage Therapeutics (SAGE) stock?
Sage Therapeutics has a consensus price target of $24.50.
Current stock price for Sage Therapeutics (SAGE)?
The stock price for Sage Therapeutics (NASDAQ: SAGE) is $12.39 last updated July 19, 2024 at 5:07 PM EDT.
Does Sage Therapeutics (SAGE) pay a dividend?
There are no upcoming dividends for Sage Therapeutics.
When is Sage Therapeutics (NASDAQ:SAGE) reporting earnings?
Sage Therapeutics’s Q2 earnings are confirmed for Wednesday, July 31, 2024.
Is Sage Therapeutics (SAGE) going to split?
There is no upcoming split for Sage Therapeutics.
What sector and industry does Sage Therapeutics (SAGE) operate in?
Sage Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.